Hostname: page-component-54dcc4c588-xh45t Total loading time: 0 Render date: 2025-10-10T15:59:03.984Z Has data issue: false hasContentIssue false

Course and severity of bipolar disorder determining TGF-beta

Published online by Cambridge University Press:  26 August 2025

S. Dodic*
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia School of Medicine, University of Belgrade
M. Velimirovic Bogosavljevic
Affiliation:
School of Medicine, University of Belgrade Institute of Clinical and Medical Biochemistry, Belgrade
V. Jurisic
Affiliation:
Faculty of Medical Sciences, University of Kragujevac, Kragujevac
M. Nesic
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia School of Medicine, University of Belgrade
M. Gostiljac
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia
M. Puric
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia School of Medicine, University of Belgrade
I. Minic
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia
B. Velickovic
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia
B. Dunjic-Kostic
Affiliation:
School of Medicine, University of Belgrade Institute of Mental Health, Belgrade, Serbia
M. Ivkovic
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia School of Medicine, University of Belgrade
M. Pantovic-Stefanovic
Affiliation:
Clinic for Psychiatry, University Clinical Centre of Serbia School of Medicine, University of Belgrade
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Bipolar Disorder (BD) is a severe and chronic psychiatric condition, with complicated course and substantially reduce psychosocial functioning. Alterations in immune response are considered to be one of the major factors underlying the etiopathogenesis of BD, causing alterations in neurotransmitter systems, neuroendocrine systems, neurotrophic factors, and producing oxidative stress. Inflammatory cytokines have potential value for the clinical diagnosis and prognosis of BD.

Objectives

The primary aim of the study was to assess the effect of disease course and clinical-characteristics on alterations of transforming growth factor-beta (TGF-beta), in BD.

Methods

This cross-sectional study included 82 patients with BD in remission. Multivariate linear regression with TGF-beta value as an outcome, and duration of illness, number of hospitalizations, residual symptoms estimated as Brief Psychiatric Rating Scale (BPRS) score, gender, and age, was used to produce the model.

Results

The explored linear regression model was significant, explaining 39.4% of the variance (p<0.001). Higher TGF-beta was predicted by less previous hospitalizations (p<0.001) and lower BPRS score (0.034), while longer duration of illness was almost significant predictor (p=0.054). Age and gender showed no predictive effect in the model.

Conclusions

The study points out to the better course of BD characterized by less episodes and less residual symptoms in determining the TGF-beta levels, potentially creating a more favorable immunological state. The importance of neuroprotective and neurodegenerative balance of immune mediators, their interplay and relation to chronicity and severity of BD should be further explored.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.